Supplementary Files
How to Cite
Abstract
Ochronotic arthropathy (alkaptonuria) is a rare hereditary disorder that poses a diagnostic dilemma. It is usually diagnosed perioperatively or by conducting investigations based on perioperative findings in the postoperative period, followed by retrospective analysis. This report discusses a case of a 37-year-old male who presented with bilateral knee pain. Radiological studies were indicative of grade III osteoarthritis but perioperatively black pigmentation was noted. Backtracking revealed it to be a case of alkaptonuria. This typically presents as early-onset osteoarthritis involving major joints like the knee, hip, shoulder, and spine. Orthopedic surgeons should have an inquisitive mind and keep this as their differential diagnosis while dealing with young patients with similar symptoms to avoid surprises during surgery. Our study aims to increase understanding of this condition for effective management and improving functional outcomes.
Keywords: Alkaptonuria, Ochronosis, Osteoarthritis, Rare Disease
References
Bernardini G, Braconi D, Zatkova A, Sireau N, Kujawa MJ, Introne WJ, et al Alkaptonuria. Nature Reviews Disease Primers. 2024 Mar 7;10(1):16. https://doi.org/10.1038/s41572-024-00498-x
Wolffenbuttel BH, Heiner-Fokkema MR, van Spronsen FJ. Preventive use of nitisinone in alkaptonuria. Orphanet journal of rare diseases. 2021 Aug 3;16(1):343. https://doi.org/10.1186/s13023-021-01977-0
Abbas K, Basit J, ur Rehman ME. Adequacy of nitisinone for the management of alkaptonuria. Annals of Medicine and Surgery. 2022 Aug 1;80. http://doi.org/10.1016/j.amsu.2022.104340
Ranganath LR, Khedr M, Milan AM, Davison AS, Hughes AT, Usher JL, et al. Nitisinone arrests ochronosis and decreases rate of progression of alkaptonuria: evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre. Molecular genetics and metabolism. 2018 Sep 1;125(1-2):127-34. https://doi.org/10.1016/j.ymgme.2018.07.011
Saini MK, Reddy NR, Reddy PJ, Reddy CD, Saini N. Clinical and surgical insights on bilateral total knee arthroplasty in ochronotic arthropathy: a case-based review. Journal of Orthopaedic Case Reports. 2021 Dec;11(12):30. 10.13107/jocr.2021.v11.i12.2554
Dewan K, MacDonald CB, Shires CB. Blue man: ochronosis in otolaryngology. Clinical Case Reports. 2022 Apr;10(4):e05717. https://doi.org/10.1002/ccr3.5717
Basanagoudar PL, Inamdar DN, Thimmegowda B R, Tubaki V. Total Joint Arthroplasty in Ochronotic Arthritis of Lower Extremities. Indian Journal of Orthopaedics. 2025 Jun 16:1-1. https://doi.org/10.1007/s43465-025-01431-4
Shashaa MN, Alkarrash MS, Alhasan Y, Kabbany SA, Rezkallah V, Alhamr A, Al-Araje MM. A shocking intraoperative diagnosis of ochronotic knee arthropathy: a case report. Annals of Medicine and Surgery. 2024 May 1;86(5):3009-12. http://doi.org/10.1097/MS9.0000000000001775
Singh A, Thorat BS, Jaspal A. Arthroplasty in ochronotic arthropathy: 3 replacements in a single patient with a long-term follow-up of 11 Years. Journal of Orthopaedic Case Reports. 2024 Feb;14(2):76. https://doi.org/10.13107/jocr.2024.v14.i02.4224
Millucci L, Spreafico A, Tinti L, Braconi D, Ghezzi L, Paccagnini E,et al. Alkaptonuria is a novel human secondary amyloidogenic disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2012 Nov 1;1822(11):1682-91. https://doi.org/10.1016/j.bbadis.2012.07.011
Bernini A, Petricci E, Atrei A, Baratto MC, Manetti F, Santucci A. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria. Scientific Reports. 2021 Nov 19;11(1):22562. https://doi.org/10.1038/s41598-021-01670-z
Introne WJ, Perry MB, Chen M. Alkaptonuria. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2003 [updated 2021 Jun 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1454/
Spears KR, Rossignol F, Perry MB, Kayser MA, Suwannarat P, O'Brien KE,et al. Patient-reported outcomes and functional assessments of patients with Alkaptonuria in a 3-year Nitisinone treatment trial. Molecular Genetics and Metabolism. 2024 Sep 1;143(1-2):108562. https://doi.org/10.1016/j.ymgme.2024.108562
Introne WJ, Perry MB, Troendle J, Tsilou E, Kayser MA, Suwannarat P, et al. A 3-year randomized therapeutic trial of nitisinone in alkaptonuria. Molecular genetics and metabolism. 2011 Aug 1;103(4):307-14. http://doi.org/10.1016/j.ymgme.2011.04.016
Ranganath LR, Cox TF. Natural history of alkaptonuria revisited: analyses based on scoring systems. Journal of inherited metabolic disease. 2011 Dec;34(6):1141-51. https://doi.org/10.1007/s10545-011-9374-9
Hughes JH, Keenan CM, Sutherland H, Edwards HR, Wilson PJ, Ranganath LR, et al. Anatomical distribution of ochronotic pigment in alkaptonuric mice is associated with calcified cartilage chondrocytes at osteochondral interfaces. Calcified Tissue International. 2021 Feb;108(2):207-18. https://doi.org/10.1007/s00223-020-00764-6
Liu Y, Li C, Zhang Z, Lu X, Zhang H. Ochronotic arthropathy effectively treated with total hip and total knee arthroplasty: a case report. Frontiers in Medicine. 2023 Sep 19;10:1212580. https://doi.org/10.3389/fmed.2023.1212580
Awad B, Elias S, Peskin B, Ghrayeb N, Khury F. A Not-So-Pleasant Surprise: Ochronotic Knee Encountered During Primary Arthroplasty. Osteology. 2025 May 31;5(2):16. https://doi.org/10.3390/osteology5020016
Couto A, Sá Rodrigues A, Oliveira P, Seara M. Ochronotic arthropathy—a rare clinical case. Oxford Medical Case Reports. 2018 Sep;2018(9):omy069. https://doi.org/10.1093/omcr/omy069
Narvekar A, Sethia SJ. Ochronotic arthropathy knee-arthroscopic diagnosis and treatment–A case report. Journal of Arthroscopic Surgery and Sports Medicine. 2024 Mar 29;4(2):48-52. http://doi.org/10.25259/JASSM_31_2022
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2026 Saad Riaz, Osama Ijaz, Talha Farooq